Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2020 Oct:80:101-102.
doi: 10.1016/j.ejim.2020.07.001. Epub 2020 Jul 7.

Linking hydroxychloroquine to hemolysis in a 'suspected' glucose-6-phosphate dehydrogenase deficient patient with COVID-19 infection - a critical appraisal

T P Afra  1 , Ram Vasudevan Nampoothiri  2 , Muhammed Razmi T  3 , N A Bishurul Hafi  1
Affiliations
Comment

Linking hydroxychloroquine to hemolysis in a 'suspected' glucose-6-phosphate dehydrogenase deficient patient with COVID-19 infection - a critical appraisal

T P Afra et al. Eur J Intern Med. 2020 Oct.
No abstract available

Keywords: Antimalarials; COVID-19; Chloroquine; Glucose-6-phosphate dehydrogenase (G6PD) deficiency; Haemolysis; Hydroxychloroquine; Lopinavir.

PubMed Disclaimer

Conflict of interest statement

Declaration of Competing Interest We declare no competing interests.

Comment in

Comment on

References

    1. De Franceschi L, Costa E, Dima F, Morandi M, Olivieri O. Acute hemolysis by hydroxycloroquine was observed in G6PD-deficient patient with severe COVD-19 related lung injury. Eur J Intern Med. 2020 https://doi.org/10.1016/j.ejim.2020.04.020. - PMC - PubMed
    1. Afra TP, Razmi TM, Bishnoi A, Hafi NAB. Hydroxychloroquine use in COVID-19: what is the basis for baseline tests? Lancet Infect Dis. 2020 https://doi.org/10.1016/S1473-3099(20)30472-2. - PMC - PubMed
    1. Youngster I, Arcavi L, Schechmaster R, Akayzen Y, Popliski H, Shimonov J. Medications and glucose-6-phosphate dehydrogenase deficiency: an evidence-based review. Drug Saf. 2010;33:713–726. - PubMed
    1. Mohammad S, Clowse MEB, Eudy AM, Criscione-Schreiber LG. Examination of hydroxychloroquine use and hemolytic anemia in G6PDH-deficient patients. Arthritis Care Res (Hoboken) 2018;70:481–485. - PubMed
    1. Commons RJ, Simpson JA, Thriemer K, Chu CS, Douglas NM, Abreha T. The haematological consequences of plasmodium vivax malaria after chloroquine treatment with and without primaquine: a worldwide antimalarial resistance network systematic review and individual patient data meta-analysis. BMC Med. 2019;17:151. - PMC - PubMed

Substances